– New treatment uses VYCROSS® technology for use on the face, neck, décolletage and hands
– Hyaluronic Acid (HA) gel designed to improve skin’s smoothness (absence of fine lines), hydration and elasticity for up to nine months with just one treatment
– Global research shows more than 50% women say appearance of skin contributes to their outer beauty

Allergan, a leading global biopharmaceutical company, announced today the launch of its new injectable treatment designed to improve skin quality and lasts up to nine months with just one treatment session. The treatment uses the unique patented VYCROSS® technology.

The new injectable treatment delivers improvements in skin smoothness (absence of fine lines), hydration and elasticity, and is designed to last for up to nine months with just one treatment.

The treatment has demonstrated efficacy in improving skin quality during a clinical trial involving 131 patients. Clinical data so far has shown significant improvements in skin quality for up to 6 months, and the clinical study is ongoing. It further enhances patient comfort by eliminating the need for multiple treatments.

Ramsey Morad, Allergan’s Vice President for India, Middle East and Africa said, “The launch of this new treatment defines Allergan’s entrance into the skin quality category – an area that we know is set to experience huge growth over the next few years in the UAE and the wider region, and with a treatment module designed to last up to nine months with just one treatment.”

“This demonstrates our ongoing commitment to delivering medical aesthetics treatment that physicians and their patients really want, that is convenient for patients and doctors, and of high quality in its results and safety,” added Morad.

Moreover, Dr. Khalid Al Awadi, Consultant Plastic and Hand Surgeon at Acacia Medical Centre also noted, “The new technology reflects a real patient need for a treatment that delivers a healthy-looking glow providing results from just one treatment. We believe that great skin can have a profound impact on patients’ everyday lives as smooth, radiant, hydrated skin from within hugely improves self-confidence.”

In the UAE, consumers spent US$2.1 billion on beauty and personal care in 2016 according to EMI, this set to rise to US$2.7 billion by 2020.

“Allergan is strongly committed to the health, safety and well-being of the practitioners and patients who put their trust in our products, as part of the company’s ongoing commitment to medical education,” noted Morad.

**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.